Clinical Trials in Detroit

Showing 6621-6640 of 14,997 trials

Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection

NCT04169815

The purpose of the pivotal study is to collect blood specimens and clinical data from patients suspected of having Heart Failure (HF), which will be tested at a future date on Natriuretic Peptide assay(s) to validate diagnostic cutoffs and assess HF severity.

Heart Failure

Beckman Coulter, Inc.2,370 participantsStarted Nov 2019

Loma Linda, California, United States • Sacramento, California, United States • Gainesville, Florida, United States +12 more locations

COMPLETEDPhase 317 miles

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

NCT03989232

This study compares the effect of two doses of semaglutide (1.0 mg and 2.0 mg) in people with type 2 diabetes (T2D). People taking part in the study will take the medicine together with their current diabetes medicine (sulphonylurea and/or metformin). Participants will get a dose of either 1.0 mg or 2.0 mg semaglutide once a week - which dose is decided by chance. Participants will inject semaglutide under the skin once a week. The study will last for about 49 weeks. Participants will have 9 clinic visits and 2 phone calls with the study doctor. At the visits participants will have blood taken and eye tests done. Women cannot take part if pregnant, breast-feeding or planning to become pregnant during the study period. Female participants who can get pregnant will be checked 11 times for pregnancy via urine tests.

Diabetes Mellitus, Type 2

Novo Nordisk A/S961 participantsStarted Jun 2019

Birmingham, Alabama, United States • Chandler, Arizona, United States • Glendale, Arizona, United States +126 more locations

Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Find Trials by Condition in Detroit

Clostridium Difficile Vaccine Efficacy Trial

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Molecular Responses Caused by UV Exposure of Human Skin

Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis

Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia

A Study of Gantenerumab in Participants With Mild Alzheimer Disease

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Safety and Efficacy in Adult Subjects With Acute Migraines

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)

A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects

Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis

Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles

A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients

Web-based Implementation for the Science of Enhancing Resilience Study

Coenzyme Q10 Phase III Trial in Gulf War Illness

Evaluating an Emergency Department Observation Syncope Protocol for Older Adults